StockWatch
·

Maharaja & Speedex India Ltd Q2 FY27 Results

SPEEDEXQ2 FY27 Results
Filing
SPEEDEX · H1 FY27 · THE VERDICT

36% growth proven; margin expansion story just got hedged

Speedex delivered strong organic numbers in H1—36% revenue growth and 19.2% EBITDA margin, up 200 bps. But management's forward guidance contradicts itself: claiming margin sustainability while later admitting margins will stay flat as OEM scales. Execution risk on fuzzy guidance clouds what should be a bullish print.

16 Nov 2026 · 6 min read
Revenue

₹78.5 Cr

+36% YoY

EBITDA

₹15.1 Cr

+52% YoY

EBITDA margin

19.2%

+200 bps YoY

PAT

₹9.9 Cr

~12.5% net margin

Speedex posted a strong H1 FY27: revenue of ₹78.5 crore (+36% YoY) and EBITDA of ₹15.1 crore (+52% YoY), with EBITDA margin expanding to 19.2% from 17.2%. The company also repaid ₹22.7 crore in short-term borrowings, bringing debt-to-equity down to 0.04. On paper, this is a clean quarter—organic growth, margin uplift, capital discipline. But the earnings call reveals a more complicated story: near-term roadmap is vague, and management's own statements contradict each other on what margins will do next.

The margin expansion claim — then the retreat

Management opened the call claiming margin expansion to 19.2% as a structural benefit from shifting in-house manufacturing from 88% to 93.5%, adding 447 bps to gross margin. That number is solid. But when pressed directly on whether margins would expand further, CEO Akash Agarwal walked it back: "EBITDA margins will stay similar (not expand) due to economies of scale offsetting brand mix gains." The headline read as margin expansion. The reality is margins will stabilize at current levels. Investors who heard "expansion" in the headline left the call hearing "hold steady."

Management's claims vs. what holds up

EBITDA grew 52% to ₹15.1 crore

Supported

Confirmed: EBITDA ₹15.1 Cr, margin 19.2% (up from 17.2%). Gross margin gain of 447 bps from in-house manufacturing shift (88% → 93.5%) drove the uplift.

50% revenue growth expected going forward

Overstated

H1 delivered 36% growth. Management guidance: 'at least 50%' but hedged as 'ballpark figures, could be 40 to 45%.' No FY27 or FY28 specific target given.

New capacity will drive ₹23–24 crore monthly revenue

Overstated

Current monthly run-rate ₹16 Cr. New capacity at 72 lakh units. Path to 103 lakh by March 2027 takes 4–5 months post-February ramp to reach 85–90% efficiency. Potential stated but timeline vague.

Margins sustainable at 19–20% EBITDA

Contradicted

H1 delivered 19.2%. Later clarification: margins will stay similar (not expand further) as OEM scaling offsets brand mix gains. Caps upside narrative.

What changed on this call

  • Capacity ramp: 62 lakh units → 72 lakh now, targeting 103 lakh by March 2027 (IPO-backed expansion)

  • Brand mix shift: own brand 14.5% of revenue, targeting 20–22% by EOY and 30% by next year; OEM 54–55% of mix

  • In-house manufacturing jumped 88% → 93.5%; gross margin up 447 bps

  • Online channel scaling: 14.5% of revenue now, targeting 20–22% by EOY via Amazon, Flipkart, Blinkit

  • Distributor network: 100 currently, targeting 150+ by year-end; expanded to 17 states, Tier 2/3 city focus

  • Debt paydown: ₹22.7 crore short-term borrowings repaid; debt/equity now 0.04

The bull-bear ledger

  • Strong organic H1: 36% revenue, 19.2% margin (+200 bps), driven by manufacturing shift and product mix

  • Capacity scaling backed by IPO proceeds; execution track record: 62 → 72 lakhs in H1

  • Structural market tailwinds: BIS quality norms and anti-dumping duties on Chinese imports (+20–25% cost premium), supply shortage favors organized players

  • Revenue diversification: online 14.5% and growing; no customer >11%; 50+ OEM/ODM counterparts; distributor network expanding

  • Margin expansion story contradicted: will stay flat at 19–20%, not expand, as OEM scales

  • Guidance vagueness: 50%+ growth as 'ballpark, could be 40–45%'; no FY27 or FY28 numeric targets; raises credibility risk

  • Working capital contradiction: stated '100% growth needs 100% funding' then 'don't see further requirement'

  • Competitive response emerging: Cello, Borosil adding capacity; if demand doesn't absorb new supply, margin/volume pressure likely

Ranked risks

Risks ranked by concern to a holder

Guidance vagueness and execution credibility

High

50%+ revenue, 10% market share in 6 years, and 19–20% margin targets lack quantified FY27/FY28 roadmap. 'Ballpark' language on a first call post-IPO raises doubt about how committed or confident management is. Hedging this early is a red flag for execution risk.

Margin expansion narrative collapse

Medium

Opening headline of margin uplift was undercut by later clarity that margins will hold steady (not expand further) as OEM scales. Suggests either unclear thinking or deliberate obfuscation. Damages the margin expansion bull thesis.

Competitive capacity additions

Medium

Cello and Borosil have added capacity. Currently market is supply-constrained (BIS/anti-dumping duties), but that tailwind is cyclical. If competitors absorb some supply constraint, Speedex faces margin and volume pressure.

Capacity ramp execution

Medium

New capacity lines take 4–5 months post-February to reach 85–90% efficiency. Any delay (machinery, labor, tech transfer) pushes 103-lakh target into Q4 FY27 or later. H1 ramp (62 → 72) was smooth; scaling to 103 is more ambitious.

Working capital surge if 50% growth sustained

Low–Medium

Management contradicted itself: '100% growth needs 100% funding' then 'don't see further requirement.' Current working capital <90 days (debtor 45–55, creditor 55–65 days). If growth accelerates or cycles lengthen, cash tightens.

How the street is positioned

At ₹268 (as of Nov 16), Speedex trades 6.78% below its all-time high (₹287.5) and 18.74% above its 52-week low (₹225.7). The stock is in the upper half of its 52-week range but has given back post-IPO highs. RSI of 57.1 is neutral (neither overbought nor oversold). Ownership is heavily skewed: promoters 63.93%, DII 11.70%, FII just 0.62%. The minimal foreign institutional stake suggests either late discovery or caution on near-term guidance and execution risk. Volume trend is normal—no panic or accumulation evident.

The price action tells the story: the market is holding the stock, not aggressively bidding it up after the call. That aligns with the fundamental read—strong H1 organic delivery deserves credit, but vague guidance and the margin hedge don't justify fresh highs. The fact that promoters own 64% and are staying committed (no block sales disclosed) is a positive insider signal. But FII sitting at <1% suggests global money is still on the sidelines—waiting for management to clarify the 50%+ growth and margin roadmap.

What to watch next
  • 1 · February 2027 capacity ramp

    New lines start production. Track whether they hit 85–90% efficiency within the stated 2-month window. Any delays push 103-lakh capacity target into Q4, raising execution risk on the full-year roadmap.

  • 2 · Q3 FY27 revenue, margin, and distribution progress

    Does online reach 20–22% by EOY? Do distributors hit 150+ by March? Compare against the 'ballpark' 40–50% growth management hedged. If Q3 shows 35%+ growth with stable margin, the vague guidance gains credibility. If growth slows to 25%+, the 50% target looks at risk.

  • 3 · Margin trajectory and OEM/brand mix

    Management said margins will hold at 19–20% as OEM scales. Watch whether gross margin continues to expand (in-house target ~95%) or plateaus. If brand mix shift drives margin UP and OEM pull-down balances it, margins defend 19–20%. If OEM demand surges and pulls mix down faster than brand uplift, margins compress.

Speedex's H1 was solid—36% growth, 19.2% EBITDA margin, and disciplined capex. The company has structural tailwinds (BIS, anti-dumping) and is executing on capacity scaling. But this is a steady quarter, not a step-change. The margin expansion story got hedged, the guidance is vague, and competitive response is emerging. Hold on the merit of strong execution and market tailwinds, but don't chase until the company quantifies its FY27–FY28 roadmap with specific revenue and margin targets. The metric to track: monthly revenue run-rate and EBITDA margin. If monthly revenue hits ₹18–19 crore by Q4 (vs. ₹16 crore now) and margins hold at 19.2%, the 50%+ growth call gains credibility. If both stall, the fuzzy guidance becomes a burden.

Informational and educational content only. Not investment advice.